冯正权,张祺箐,王 莉.中药联合化疗对中晚期非小细胞肺癌免疫功能的影响[J].中国肿瘤,2014,23(5):417-420.
中药联合化疗对中晚期非小细胞肺癌免疫功能的影响
Effect of Traditional Chinese Medicine Combined with Chemotherapy on Immunity in Patients with Advanced Non-Small Cell Lung Cancer
投稿时间:2013-10-12  
DOI:10.11735/j.issn.1004-0242.2014.05.A015
中文关键词:  非小细胞肺癌  中医药  T淋巴细胞亚群  免疫功能
英文关键词:non-small cell lung cancer  Traditional Chinese Medicine  T-lymphocyte subsets  immune function
基金项目:浙江省中医药管理局资助项目(2010ZA034)
作者单位
冯正权 浙江省立同德医院/中国中医科学院广安门医院 
张祺箐 浙江中医药大学 
王 莉 浙江中医药大学 
摘要点击次数: 1989
全文下载次数: 1014
中文摘要:
      摘 要:[目的] 观察中药联合化疗治疗中晚期非小细胞肺癌患者T淋巴细胞亚群变化及其临床意义。[方法] 219例中晚期非小细胞肺癌患者,分为单纯化疗组和中药联合化疗组,对两组的T淋巴细胞亚群变化进行对比分析。[结果] 单纯化疗组94例化疗后患者CD3+、CD4+、CD4+/CD8+、NK细胞比例与化疗前相比均显著性升高(P<0.01);化疗后CD8+细胞比例有所降低,但无统计学差异(P>0.05)。中药联合化疗组125例化疗后患者CD4+、CD4+/CD8+细胞比例与化疗前比较均显著性升高(P<0.01),CD8+细胞比例显著性降低(P<0.01),化疗后CD3+、NK细胞比例有所升高,但无统计学意义(P>0.05)。与单纯化疗组相比,中药联合化疗组化疗后CD8+比例降低和CD4+/CD8+比例升高更明显(P均<0.05)。[结论] 中晚期肺癌患者免疫功能处于抑制状态,单纯化疗与中药联合化疗均能改善免疫功能,且中药联合化疗优于单纯化疗组。
英文摘要:
      Abstract:[Purpose] To investigate the changes and clinical significance of T lymphocyte subset after Traditional Chinese Medicine(TCM) combined with chemotherapy in patients with advanced non-small cell lung cancer. [Methods] A total of 219 cases with advanced non-small cell lung cancer were divided into chemotherapy group and TCM combined with chemotherapy group,changes in T lymphocyte subset between two groups was analyzed. [Results] In chemotherapy group(94 patients with NSCLC),the level of CD3+,CD4+,CD4+/CD8+ ratio and NK cell after chemotherapy were increased significantly(P<0.01);the CD8+ cells had no significant change(P>0.05). While,the level of CD4+ and CD4+/CD8+ ratio after chemotherapy were increased significantly in TCM combined with chemotherapy group(125 patients)(P<0.01);the level of CD8+ cells was decreased significantly(P<0.01);and CD3+ and NK cells had no significant change(P>0.05). Compared with chemotherapy group,the CD8+ cells after treatment decreased significantly(P<0.05) and the ratio of CD4+/CD8+ were significantly higher(P<0.05) in TCM combined with chemotherapy group.[Conclusion] The patients with advanced NSCLC are in a state of immune suppression,chemotherapy and TCM combined with chemotherapy both can improve immunity,and TCM combined with chemotherapy is better than chemotherapy alone.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器